MedTrace Logo

The PK/PD of Deoxycholic Acid Amphotericin B in Invasive Fungal Infection Patients With Sepsis/Septic Shock

NCT05642624 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2022-12-08

No results posted yet for this study

Summary

To explore the PK/PD of deoxycholic amphotericin B in invasive fungal infection patients with sepsis/septic shock;To compare the PK/PD of deoxycholic amphotericin B in invasive fungal infection patients with sepsis and septic shock.

Conditions

Interventions

DRUG

Deoxycholic acid amphotericin B

Starting with 1mg and increasing by 5-25mg daily until the maintenance dose is 50mg/d.

Sponsors & Collaborators

  • Southeast University, China

    lead OTHER

Principal Investigators

  • Huang Yingzi, PHD · Zhongda Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-28
Primary Completion
2022-06-28
Completion
2022-06-28

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05642624 on ClinicalTrials.gov